Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantAPEX PHARMA MARKETING PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
INTRAVENOUS, INTRAMUSCULAR
Medical Information
M01AH04
Manufacturer Information
APEX PHARMA MARKETING PTE. LTD.
QILU PHARMACEUTICAL (HAINAN) CO., LTD.
Active Ingredients
Documents
Package Inserts
Parecoxib-AFT Powder for Solution for Injection PI.pdf
Approved: May 17, 2024